Biorad sec filings

WebApr 11, 2024 · CENTRAL TRUST Co trimmed its position in Bio-Rad Laboratories, Inc. (NYSE:BIO – Get Rating) by 74.5% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 135 shares of the medical research company’s stock after … WebJul 27, 2024 · 10x's Tuesday SEC filing related to the global settlement says the company also agreed to pay Bio-Rad over $29 million in royalties and interest related to sales of GEM products from the date of ...

Bio-Rad Laboratories, Inc. - Financials - SEC Filings

WebInvestor Relations Financial Reports & SEC Filings Financial Reports. QIAGEN N.V.reports its annual results under U.S. GAAP (SEC filing) due to the listing of our stock at the New York Stock Exchange. As a company established under the laws of The Netherlands we are required by law to also report under IFRS accounting standards. WebFeb 17, 2024 · HERCULES, Calif.—February 16, 2024 -- Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, … imbalanced nutrition rationale https://marinchak.com

Qiagen N.V. - Investor Relations - Financial Reports & SEC Filings ...

WebApr 10, 2024 · Sumitomo Mitsui DS Asset Management Company Ltd raised its position in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO – Get Rating) by 1.7% in the fourth quarter, according to its most recent ... WebApr 10, 2024 · The sale was disclosed in a legal filing with the SEC, which is accessible through this link. 27.40% of the stock is owned by company insiders. Bio-Rad Laboratories Price Performance WebJan 9, 2024 · All companies, foreign and domestic, are required to file registration statements, periodic reports, and other forms electronically through EDGAR. list of ingredients in herbs de provence

Bio-Rad Laboratories, Inc. (NYSE:BIO) Shares Purchased by …

Category:Bio-Rad Laboratories, Inc. (NYSE:BIO) Shares Purchased by …

Tags:Biorad sec filings

Biorad sec filings

Bio-Rad Reports First-Quarter 2024 Financial Results

Webassist Bio -Rad Russia in the sale of Bio -Rad products to the Russian government. 8. Bio -Rad Laboratories 6LQJDSRUH 3WH /LPLWHG ³%LR -5DG6LQJDSRUH´ is %LR … WebDownload Bio-Rad annual reports, SEC filings, and quarterly results. Obtain investor kits, corporate information, and answers to Company and stock FAQs here.

Biorad sec filings

Did you know?

WebSEC Filing Details. Form 4. 04/11/2024. Statement of Changes in Beneficial Ownership. PDF Format Download (opens in new window) Word Format Download (opens in new … WebApr 11, 2024 · Shares of NYSE:BIO opened at $469.95 on Tuesday. The company has a debt-to-equity ratio of 0.12, a quick ratio of 4.29 and a current ratio of 5.55. Bio-Rad Laboratories, Inc. has a 52-week low of ...

WebApr 13, 2024 · Vaughan Nelson Investment Management L.P. boosted its holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO - Get Rating) by 202.0% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission.The firm owned 3,715 shares of the medical research company's stock after … WebApr 11, 2024 · The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 27.40% of the company's stock. Bio-Rad Laboratories Trading Up 0.8 %. Shares of Bio-Rad Laboratories stock opened at $469.95 on Tuesday. Bio-Rad Laboratories, Inc. has a twelve month low of $344.63 and a twelve …

WebApr 28, 2024 · Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, today announced financial results for the first quarter ended March 31, 2024. First-quarter 2024 net sales were $700.1 million, a decrease of 3.7 percent compared to $726.8 million reported for the first quarter of 2024. … WebLife Science Research. Bio-Rad Products. Genomics; Antibodies; Flow Cytometry; Transfection; Electrophoresis and Blotting; Imaging Systems & Software ; Bio-Plex Multiplex Immunoassay System

WebApr 13, 2024 · Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO – Get Rating) have been assigned an average recommendation of “Buy” from the six research firms that are …

WebApr 6, 2024 · Bio-Rad Laboratories, Inc. SEC Filing - Quarterly Report (10-Q) October 28, 2024 Bio-Rad Laboratories, Inc. (BIO) Q3 2024 Earnings Call Transcript Bio-Rad Labs … imbalanced nutrition nursing outcomesWebJan 6, 2024 · Download Bio-Rad annual reports, SEC filings, and quarterly results. Get investor kits, corporate information, and answers to company and stock FAQs. list of ingredients in the pfizer vaccine cdcWebAccess Bio-Rad's most recent SEC filings. Please note that Bio-Rad does not maintain or provide information to Q4 Inc. In addition, Bio-Rad makes no representations or … imbalanced nutrition related to depressionWebBio-Rad Laboratories (BIO) Alerts Watch Help Go To: SEC Filings Types of filings include: Registration Statement - details of the business and type of investments offered 10-K … imbalanced nutrition expected outcomeWebExporting SEC Filings to Excel. XBRL is the new technology that is being used by companies to report filings to the SEC. At first it was the giant companies that complied with XBRL standards but all companies now support this which makes for pulling data easier. But let’s get down to what you really want. Exporting financial statements ... imbalanced nutrition care plansimbalanced nutrition related to nauseaWebFind the latest SEC Filings data for Bio-Rad Laboratories, Inc. Class A Common Stock (BIO) at Nasdaq.com. list of ingredients in mary kay products